Mucinous Colorectal Cancer is Associated With Expression of the TIM-3 Immune Checkpoint Independently of Microsatellite Instability (MSI) Status

被引：1
|
作者：
Emer O’Connell
Manuela Salvucci
Ian S. Reynolds
Deborah A. McNamara
John P. Burke
Jochen H. M. Prehn
机构：
[1] Beaumont Hospital,Department of Colorectal Surgery
[2] Royal College of Surgeons in Ireland,Department of Physiology and Medical Physics
[3] Royal College of Surgeons in Ireland,Department of Surgery
[4] Royal College of Surgeons in Ireland,Centre for Systems Medicine
来源：
Annals of Surgical Oncology | 2021年 / 28卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：7999 / 8006
页数：7
相关论文
共 50 条
  • [31] Time to target TIM-3 in colorectal cancer: TIM-3 expression to predict survival outcomes in patients in CALGB (Alliance)/SWOG 80405
    Algaze, Sandra
    Yang, Yan
    Millstein, Joshua
    Battaglin, Francesca
    Soni, Shivani
    Mittal, Pooja
    Ashouri, Karam
    Jayachandran, Priya
    Arai, Hiroyuki
    Lo, Jae Ho
    Zhang, Wu
    Torres-Gonzalez, Lesly
    Wong, Alexandra
    Lenz, Heinz-Josef
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [32] Family History of Colorectal Cancer Is Not Associated with Colorectal Cancer Survival Regardless of Microsatellite Instability Status
    Phipps, Amanda I.
    Ahnen, Dennis J.
    Campbell, Peter T.
    Win, Aung Ko
    Jenkins, Mark A.
    Lindor, Noralane M.
    Gryfe, Robert
    Potter, John D.
    Newcomb, Polly A.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2014, 23 (08) : 1700 - 1704
  • [33] THE IMPACT OF MICROSATELLITE INSTABILITY (MSI) STATUS ON CHEMOTHERAPY TREATMENT IN AFRICAN-AMERICAN PATIENTS WITH COLORECTAL CANCER
    Asemota, Joseph
    Okereke, Ifeanyichukwu
    Igbinosa, Owen
    Adidam, Sneha
    Saleh, Mohammed
    Ojo, Ademola
    Ojukwu, Somtochukwu G.
    Gboluaje, Temitayo
    Shokrani, Babak
    Sherif, Zaki A.
    Lee, Edward L.
    Brim, Hassan
    Ashktorab, Hassan
    GASTROENTEROLOGY, 2022, 162 (07) : S521 - S521
  • [34] Aurora-A Expression Is Independently Associated with Chromosomal Instability in Colorectal Cancer
    Baba, Yoshifumi
    Nosho, Katsuhiko
    Shima, Kaori
    Irahara, Natsumi
    Kure, Shoko
    Toyoda, Saori
    Kirkner, Gregory J.
    Goel, Ajay
    Fuchs, Charles
    Ogino, Shuji
    NEOPLASIA, 2009, 11 (05): : 418 - 425
  • [35] Tim-3: An inhibitory immune checkpoint is associated with maternal-fetal tolerance and recurrent spontaneous abortion
    Zhu, Wu
    Tan, Yue-qiu
    Wang, Fu-yan
    CLINICAL IMMUNOLOGY, 2022, 245
  • [36] Association of Primary Resistance to Immune Checkpoint Inhibitors in Metastatic Colorectal Cancer With Misdiagnosis of Microsatellite Instability or Mismatch Repair Deficiency Status
    Cohen, Romain
    Hain, Elisabeth
    Buhard, Olivier
    Guilloux, Agathe
    Bardier, Armelle
    Kaci, Rachid
    Bertheau, Philippe
    Renaud, Florence
    Bibeau, Frederic
    Flejou, Jean-Francois
    Andre, Thierry
    Svrcek, Magali
    Duval, Alex
    JAMA ONCOLOGY, 2019, 5 (04) : 551 - 555
  • [37] PDL-1 expression in colorectal cancer is associated with microsatellite instability
    Tziakou, P.
    Marinis, T.
    Arkoumani, E.
    Zizi-Sermpetzoglou, A.
    VIRCHOWS ARCHIV, 2019, 475 : S211 - S211
  • [38] Immune Checkpoint Inhibition in Metastatic Colorectal Cancer Harboring Microsatellite Instability or Mismatch Repair Deficiency
    Cohen, Romain
    Colle, Raphael
    Pudlarz, Thomas
    Heran, Maximilien
    Duval, Alex
    Svrcek, Magali
    Andre, Thierry
    CANCERS, 2021, 13 (05) : 1 - 10
  • [39] The TIM-3 Rs10053538 Polymorphism Is Associated with Clinical Prognosis of Colorectal Cancer
    Liu, Yabin
    Duan, Ya
    Yang, Ning
    Li, Binghui
    Kong, Dexian
    IMMUNOLOGICAL INVESTIGATIONS, 2022, 51 (05) : 1302 - 1312
  • [40] Consistency and heterogeneity of microsatellite instability (MSI) status in paired biopsy and surgical specimens of colorectal cancer: A necessity for MSI reassessment after treatment?
    Cui, Wei
    Shi, Shanshan
    Sun, Linyong
    Wei, Baoye
    Liu, Fei
    Xi, Yanfeng
    Xie, Bin
    Zhang, Zhihong
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 149 - 149
12345